Group 1 - A total of 573 stocks reported their latest shareholder numbers as of July 10, with 232 stocks showing a decrease compared to the previous period [1][3] - Among the stocks with a decline in shareholder numbers, 16 stocks experienced a drop of over 10%, with the largest decrease seen in Futec Technology, which fell by 25.89% to 9,703 shareholders [3][4] - The average increase for concentrated stocks since June 21 was 6.69%, outperforming the Shanghai Composite Index, which rose by 4.32%, with 63% of concentrated stocks yielding excess returns relative to the market [2][3] Group 2 - The stock with the highest increase in shareholder numbers was Hengtong Co., which rose by 13.67% since June 21, despite a decline in shareholder numbers [2][3] - The industry sectors with the most concentrated stocks include machinery, electronics, and basic chemicals, with 27, 24, and 22 stocks respectively [3][4] - Among the concentrated stocks, Guoyuan Securities reported a net profit increase of 40.44% in its half-year performance, while Haowu Co. is expected to see a net profit increase of 265.87% [4]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of the company, Da Dongfang, within the medical services industry [1][2] - As of July 11, Da Dongfang's closing price was 5.13 yuan, reflecting a decline of 3.93%, with a rolling PE ratio of 74.22 times and a total market capitalization of 4.539 billion yuan [1] - The average PE ratio for the medical services industry is 44.27 times, with a median of 46.60 times, positioning Da Dongfang at 37th place within the industry [1][2] Group 2 - As of March 31, 2025, Da Dongfang had 82,560 shareholders, a decrease of 10,189 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] - The main business operations of Da Dongfang include department store retail, Sanfengqiao brand management, and healthcare services, with notable products in these sectors [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 921 million yuan, a year-on-year decrease of 8.55%, and a net profit of 39.932 million yuan, a year-on-year decline of 78.14%, with a sales gross margin of 19.46% [1]

Group 1 - The core viewpoint of the article highlights the performance and valuation of Beibu Gulf Port, which closed at 8.21 yuan, down 1.08%, with a rolling PE ratio of 19.00 times and a total market value of 19.455 billion yuan [1] - The average PE ratio for the shipping and port industry is 14.25 times, with a median of 14.78 times, placing Beibu Gulf Port at the 24th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders for Beibu Gulf Port is 37,861, a decrease of 3,810 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Beibu Gulf Port Co., Ltd. specializes in container and bulk cargo handling, storage, port value-added services, and supporting port services, with main products including loading and unloading, towing services, cargo surveying, and agency services [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 1.643 billion yuan, a year-on-year increase of 6.73%, while net profit was 196 million yuan, reflecting a year-on-year decrease of 49.87%, with a sales gross margin of 29.74% [1]

Group 1 - The company, Shanghai Data Port Co., Ltd., closed at 24.55 yuan on June 24, with a rise of 4.78%, resulting in a rolling PE ratio of 125.53 times and a total market value of 17.636 billion yuan [1] - The average PE ratio for the internet services industry is 71.57 times, with a median of 78.10 times, placing the company at the 119th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders increased to 147,970, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - In the first quarter of 2025, the company reported operating revenue of 395 million yuan, a year-on-year increase of 3.57%, and a net profit of 44.056 million yuan, reflecting a year-on-year growth of 23.22% [2] - The company's sales gross margin stands at 29.19% [2] - The company has received 11 honors at various levels, including two national-level honors, which reinforce its technological advantages and leading position in economic development [1]

Company Overview - Bohai Leasing's closing price on June 19 was 3.13 yuan, down 1.88%, with a rolling PE ratio of 16.34 times and a total market capitalization of 19.358 billion yuan [1] - The company ranks 9th in the diversified financial industry, which has an average PE ratio of 61.75 times and a median of 26.44 times [1] Shareholder Information - As of March 31, 2025, Bohai Leasing had 133,937 shareholders, a decrease of 13,386 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Business Operations - Bohai Leasing specializes in leasing services and production for aircraft, containers, domestic infrastructure, high-end equipment, commercial properties, and new energy [1] - The main products include aircraft leasing, aircraft sales, container leasing, container sales, operating leasing, financing leasing, and financing leasing consulting [1] Financial Performance - In the first quarter of 2025, the company reported operating revenue of 17.117 billion yuan, a year-on-year increase of 99.82%, and a net profit of 669 million yuan, up 72.21%, with a gross profit margin of 24.75% [1]

Group 1 - The core viewpoint of the article highlights that Aier Eye Hospital's stock closed at 12.47 yuan, down 1.42%, with a rolling PE ratio of 31.38 times and a total market capitalization of 116.288 billion yuan [1] - The average PE ratio for the medical services industry is 41.83 times, with a median of 45.41 times, placing Aier Eye Hospital at the 22nd position in the industry ranking [1] - As of March 31, 2025, Aier Eye Hospital had 347,329 shareholders, a decrease of 31,805 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Aier Eye Hospital's main business includes diagnosis and surgical services for various eye diseases, with key products being refractive projects, cataract projects, anterior segment projects, posterior segment projects, and vision services [1] - In the latest quarterly report for Q1 2025, the company achieved an operating revenue of 6.026 billion yuan, a year-on-year increase of 15.97%, and a net profit of 1.050 billion yuan, up 16.71%, with a gross profit margin of 48.02% [1]

Company Overview - Nanjing Commercial Travel Co., Ltd. focuses on commercial trade and tourism, with main products including textiles, machinery, chemical raw materials, metal materials, non-metallic ores, tourism services, and retail goods [1] - As of March 31, 2025, the company had 30,086 shareholders, a decrease of 906 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Financial Performance - For Q1 2025, the company reported revenue of 191 million yuan, a year-on-year decrease of 7.98%, and a net profit of 3.51 million yuan, down 80.03% year-on-year, with a gross profit margin of 22.30% [1] - The current stock price is 9.49 yuan, reflecting a 9.97% increase, with a rolling PE ratio of 93.39, marking a new low in 27 days [1] Industry Comparison - The average PE ratio for the trade industry is 44.34, with a median of 33.80, positioning Nanjing Commercial Travel at 31st place within the industry [1] - The industry average market capitalization is 8.69 billion yuan, while the median is 7.29 billion yuan [2]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Mingde Biological Technology Co., Ltd., particularly its stock performance and industry comparison [1][2] - As of June 3, the closing price of Mingde Biological was 19.71 yuan, with a PE ratio of 118.10, marking a new low in 111 days, and a total market capitalization of 4.583 billion yuan [1] - The average PE ratio for the medical device industry is 50.80, with a median of 36.71, positioning Mingde Biological at the 108th rank within the industry [1][2] Group 2 - As of April 18, 2025, the number of shareholders for Mingde Biological was 25,248, a decrease of 345 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The main business of the company includes the research, production, sales, and service of in vitro diagnostic reagents and instruments, as well as solutions for critical care information and third-party medical testing services [1] - In the latest quarterly report for Q1 2025, the company reported a revenue of 69.96 million yuan, a year-on-year increase of 14.76%, but a net loss of approximately 3.66 million yuan, representing a year-on-year decline of 111.43%, with a gross profit margin of 16.37% [1]

Group 1 - The core viewpoint of the news is that Shennong Group's stock performance and financial results indicate significant growth potential within the agricultural and livestock industry [1] - As of May 29, Shennong Group's closing price was 27.12 yuan, with a PE ratio of 15.49 and a total market capitalization of 14.234 billion yuan [1] - The average PE ratio for the agricultural and livestock industry is 42.73, with Shennong Group ranking 34th among its peers [1] Group 2 - As of May 20, 2025, Shennong Group had 19,188 shareholders, an increase of 689 from the previous count, with an average holding value of 352,800 yuan per shareholder [1] - The company's main business includes feed processing and sales, pig farming and sales, pig slaughtering, and fresh pork food sales, with key products being feed, commodity pigs, and various pork products [1] - In the first quarter of 2025, Shennong Group reported revenue of 1.472 billion yuan, a year-on-year increase of 35.97%, and a net profit of 229 million yuan, reflecting a staggering year-on-year growth of 6510.85% [1]

5月26日，泰山石油今日收盘6.27元，上涨1.13%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到22.54倍，总市值30.15亿元。 从行业市盈率排名来看，公司所处的石油行业行业市盈率平均12.63倍，行业中值25.57倍，泰山石油排 名第14位。 股东方面，截至2025年5月20日，泰山石油股东户数34768户，较上次减少416户，户均持股市值35.28万 元，户均持股数量2.76万股。 最新一期业绩显示，2025年一季报，公司实现营业收入8.02亿元，同比-4.76%；净利润5296.57万元，同 比185.74%，销售毛利率17.68%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)14泰山石油22.5430.352.7630.15亿行业平均 12.6311.321.171698.99亿行业中值25.5729.381.5653.24亿1茂化实华-26.67-23.823.2419.86亿2沈阳化 工-25.70-18.142.1630.49亿3中晟高科-20.05-13.477.4922.93亿4博汇股份-9.52-7.917.2124.28亿5国际实 业-5.92-5.9 ...